$ALXN Headlines Bed Bath, Starz gain; Citizens

New Post Public Reply Private Reply Replies (0) Message Board

Sep 25, 2014 at 10:32 AM

$ALXN Headlines

Bed Bath, Starz gain; Citizens Financial debuts 3:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 3:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 4:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 9:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 4:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential 7:41 a.m. Today - 247WallSt.com
Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog 11:05 a.m. Sept. 24, 2014 - Zacks.com
Alexion Pharmaceuticals, Inc. (ALXN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Sept. 23, 2014 - Zacks.com
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog 3:20 p.m. Sept. 22, 2014 - Zacks.com
IBD 50 Stocks Setting Up, Including These 5 Medicals 5:35 p.m. Sept. 19, 2014 - Investors Business Daily
Encouraging Phase 2 results for Alexion's asfotase alfa 7:42 a.m. Sept. 19, 2014 - Seeking Alpha
SNN, ALXN And ACT, 3 Health Care Stocks Pushing The Sector Lower 1:04 p.m. Sept. 17, 2014 - TheStreet.com
Stock Market News for September 17, 2014 - Market News 10:10 a.m. Sept. 17, 2014 - Zacks.com
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Biotech Stocks With Upside Target Ebola, Liver Disease 6:30 a.m. Sept. 16, 2014 - InvestorPlace.com
Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise? 2:30 p.m. Sept. 15, 2014 - Seeking Alpha
Stock Market News for September 11, 2014 - Market News 10:10 a.m. Sept. 11, 2014 - Zacks.com
Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs 10:02 a.m. Sept. 11, 2014 - TheStreet.com
Short Sellers Remain Vigilant Against Biotechs 9:45 a.m. Sept. 11, 2014 - 247WallSt.com
Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog 5:30 p.m. Sept. 9, 2014 - Zacks.com
SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks 8:58 a.m. Sept. 8, 2014 - 247WallSt.com
Japanese regulators tag asfotase alfa an orphan drug for rare bone disorder 7:06 a.m. Sept. 8, 2014 - Seeking Alpha
Alexion Pharmaceuticals: FDA Findings An Easy Fix 5:45 p.m. Sept. 5, 2014 - Investors Business Daily
Insider Trading Alert - BRCM, ALXN And JLL Traded By Insiders 12:03 p.m. Sept. 5, 2014 - TheStreet.com

Paediatric Patients with Hypophosphatasia Receiving Investigational Asfotase Alfa Had Sustained Improvements in Growth and Physical Function 4:49 a.m. Sept. 19, 2014 - BusinessWire - BZX
Alexion Strengthens and Broadens Its Executive Leadership Team 7:30 a.m. Sept. 17, 2014 - BusinessWire - BZX
Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years 5:30 p.m. Sept. 14, 2014 - BusinessWire - BZX
NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England 7:01 p.m. Sept. 3, 2014 - BusinessWire - BZX
Technical Updates, Upcoming Conferences, Drug Trials, and Acquisition Updates - Research Reports on SL Green, Allstate, HCA Holdings, Alexion and Salix 9:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Alexion to Present at Investor Conferences 10:00 a.m. Aug. 28, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation 6:30 a.m. Aug. 25, 2014 - BusinessWire - BZX
Technical Updates, Study Outcomes, Project Approvals, and Quarterly Performance Reviews - Research Reports on Alexion, Novartis, CB&I, L-3 and Emerson 8:40 a.m. Aug. 15, 2014 - PR Newswire - PRF
Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting 4:57 p.m. Aug. 13, 2014 - BusinessWire - BZX
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 2:44 p.m. Aug. 11, 2014 - ACCESSWIRE
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis 9:10 a.m. Aug. 7, 2014 - PR Newswire - PRF
European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 6:30 a.m. Aug. 1, 2014 - BusinessWire - BZX
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:15 a.m. July 24, 2014 - BusinessWire - BZX
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
Alexion Announces the Appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to Its Board of Directors 8:02 a.m. July 16, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Second Quarter 2014 Results on Thursday, July 24, 2014 10:00 a.m. July 10, 2014 - BusinessWire - BZX
Market Activity and Upcoming Quarterly Results - Analyst Notes on Bristol-Myers Squibb, Abbott, Alexion, Mallinckrodt and Baxter 6:10 a.m. July 8, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Empirik.ai's $21M for AI in Infrastructure Revolution

AI-Powered Infrastructure Takes the Stage Well, here's a tech gambit going full steam: empirik.ai just hit the digital scene with a $21 million war chest. Fresh out of the stealth shadows, they've got big names like Sequoia Capital, S32, Canapi Ventures, and Alumni Ventures stamping their ticket. What's the fuss? They're rolling out the first AI agent designed to...

Epson & The Photo Managers Highlight Memories in Sept.

A Focus on Memory Preservation I remember a time when you kept memories in photo albums, dusty boxes in basements. Now, folks aim to digitize those moments before they're lost forever. With September here, Epson and The Photo Managers are telling us it's time for action. And hey, the campaign’s got a catchy name, 'One Photo, One Story.' Simple, yet it urges us all to...

ZPMC Names Two New 38,000 DWT Vessels for Chipolbrok

Navigating Uncharted Waters with New Vessels Some days, you see a giant leap in an industry and think, "Well, someone's got ambition." Here, we're talking about ZPMC's gutsy naming ceremony for two spanking new 38,000 DWT multipurpose heavy-lift ships destined for Chipolbrok, happening fresh off the docks in Shanghai. Specifications That Make Waves Imagine a vessel the...

Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Balázs Nagy's Bold Move: Transforming AI Workforce

New Horizons in AI: Balázs Nagy Leads There's always that one name that shakes things up, and today it's Balázs Nagy. The guy's not just playing in the AI sandbox; he's leveling the whole thing up with Project NoéMI. He's the big cheese at TheNewPush LLC, beyond just a job title. Nagy’s diving headfirst into AI workforce development in a world screaming for change....

Art Ave Spurs Rebirth in Downtown DC: A Template for Revival

Turning Streets into Art Galleries No one would have believed a stretch of DC's bureaucratic offices was about to morph into a vibrant destination worthy of major art aficionados. But here we are, tipping our hats to the Golden Triangle Business Improvement District (BID), who just snagged the IDA Downtown Achievement Award of Excellence for their Art Ave project. Not...

Elbphilharmonie Hamburg: 10th Anniversary Marks Milestone

Elbphilharmonie's Impact on Hamburg's Cultural Landscape Here we are, staring down the first decade of the Elbphilharmonie, and boy, if that isn't a testament to sticking your neck out for culture, I don't know what is. Opened back on January 11, 2017, this concert hall started as just another controversial project, folks wagging tongues about costs and ambition. But...

Codoxo Snags 2026 Award for AI Payment Innovation

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Behavioral Crisis Center Saves Mobile $101M Since 2021

AltaPointe Saves Millions While Supporting Community Health Let's dig into this remarkable achievement by the AltaPointe Behavioral Health Crisis Center. Since opening its doors in May 2021, the Mobile, Alabama facility has notched up a mind-boggling $101.5 million in community savings. This isn’t merely about numbers on a ledger—it's about real human impact, better...

SCO at 25: China's Strategic Push for Regional Growth

There's a new beat coming out of Central Asia, and it's resonating all the way from China's boardrooms to the barren landscapes of the Gobi Desert. With the Shanghai Cooperation Organization (SCO) celebrating its 25th anniversary, we're witnessing a pivot from a security-centric setup to a full-blown economic collaboration machine. The Landscape of SCO's Evolution Look,...